Michelle Zhu
Director
25+ year of R&D and managerial experience in stem cell and cell therapy industry. Ms. Zhu started her career in stem cell research at Harvard Medical School, and is now the President of ThermoGenesis Holdings Inc. (Nasdaq:THMO)
Director
25+ year of R&D and managerial experience in stem cell and cell therapy industry. Ms. Zhu started her career in stem cell research at Harvard Medical School, and is now the President of ThermoGenesis Holdings Inc. (Nasdaq:THMO)
PHD, Director
25+ years of experience in cancer immunology. Extensive managerial experiences in Schering AG, Immunnova, Sanpower Group, Dendreon. Dr. Ying obtained his PhD from Stanford and trained with Dr. Steven Rosenberg at National Cancer Institute.
Director
25+ year of R&D and managerial experience in stem cell and cell therapy industry. Ms. Zhu started her career in stem cell research at Harvard Medical School, and is now the President of ThermoGenesis Holdings Inc. (Nasdaq:THMO)
PhD | Head of Biology
25+ years of experience in cell therapy drug discovery and development. In-depth and extensive experiences in leading molecular & cell biology, cancer biology and cell therapeutic studies. Past experiences include STEMCELL Technology, Aastrom Biosciences (Nasdaq:ASTM) and Genetech.
MBA | Chief Operating and Marketing Officer
25+ year of managerial experience in business consulting and operation in healthcare insurance industry. Served as Consulting Partner at IBM for commercial healthcare sector. MBA from Indiana University.
MD | Chief Medical Officer
40+ year of experience in years experiences with immunology, hematology and blood transfusion medicine.
Served as Chief Medical Directors at various public and private blood banks.
Strategic financial executive with 25+ years of financial, transactional, and operational experience. Broad experience as CFO, CEO, Board Director, PE/VC Investor, and M&A professional of public and VC/PE backed Life Sciences, Healthcare, Medtech, and Technology companies. MBA from Wharton School of Business.
PhD, MBA | Chief Executive Officer
20+ years R&D and managerial experiences in life sciences and pharmaceutical industry, including Pfizer and other public companies; advanced 20+ products into different stages of clinical trials; adjunct professor at Peking University. PhD in Immunology from Washington University in St. Louis, MBA from Emory University.